Literature DB >> 7044363

Evaluation of the potential of systemic slow release chemical treatments for control of the cattle tick (Boophilus microplus) using ivermectin.

J Nolan, H J Schnitzerling, P Bird.   

Abstract

Stall and field trials with cattle infested with various acaricide-resistant strains of cattle tick, have demonstrated the potential of ivermectin as a systemic tickicide. A dosage of 200 micrograms/kg, administered subcutaneously to animals naturally infested in the field, gave satisfactory tick control for 21 days, after an initial lag period of 2 days immediately following treatment, during which significant numbers of ticks survived. Daily subcutaneous treatments, administered so as to simulate slow release, indicated that a dosage of 15 micrograms/kg/day should give complete tick control if the chemical could be released continuously from a subcutaneous implant. The potency of ivermectin assessed by in vitro tests against engorged adults, suggests that the tickicidal activity could be associated with the parent compound per se rather than a metabolite.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7044363     DOI: 10.1111/j.1751-0813.1981.tb05778.x

Source DB:  PubMed          Journal:  Aust Vet J        ISSN: 0005-0423            Impact factor:   1.281


  4 in total

1.  A review of the pharmacology and clinical uses of ivermectin.

Authors:  T B Barragry
Journal:  Can Vet J       Date:  1987-08       Impact factor: 1.008

2.  Control of induced infestations of three African multihost tick species with sustained-release ivermectin.

Authors:  M D Soll; I H Carmichael; G E Swan; S J Gross
Journal:  Exp Appl Acarol       Date:  1989-07       Impact factor: 2.132

3.  Ocular onchocerciasis: current management and future prospects.

Authors:  Olufemi Emmanuel Babalola
Journal:  Clin Ophthalmol       Date:  2011-10-13

Review 4.  Combining indoor and outdoor methods for controlling malaria vectors: an ecological model of endectocide-treated livestock and insecticidal bed nets.

Authors:  Laith Yakob; Mary Cameron; Jo Lines
Journal:  Malar J       Date:  2017-03-13       Impact factor: 2.979

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.